Funding for this research was provided by:
Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH&RC), Lahore, Pakistan (ONC-BRCA-002)
German Cancer Research Center (DKFZ), Heidelberg, Germany
Received: 23 May 2019
Accepted: 2 September 2019
First Online: 11 September 2019
Ethics approval and consent to participate
: This study was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines. It was approved by the ethics committee of Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH&RC), Lahore Pakistan. The ethics committee name is the “Institutional Review Board”. The approval number is ONC-BRCA-002. Written informed consent was obtained from all study participants.
: Not applicable
: The authors declare that they have no competing of interests.